{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:30:00Z","timestamp":1793478600479,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pnpbp.2026.111954","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:05:40Z","timestamp":1790867140000},"page":"111954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Methylphenidate treatment status and subclinical atherosclerosis in children and adolescents with ADHD: a cross-sectional comparative study"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6436-4394","authenticated-orcid":false,"given":"Mehmet Akif","family":"Ak\u0131nc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3381-2331","authenticated-orcid":false,"given":"Necati","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0713-3802","authenticated-orcid":false,"given":"Hayrullah","family":"Alp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111954_bb0005","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jacc.2019.08.012","article-title":"From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review","volume":"74","author":"Ahmadi","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0010","first-page":"256","article-title":"Evaluation of hematological inflammatory markers in children and adolescents with attention deficit\/hyperactivity disorder","volume":"122","author":"Ak\u0131nc\u0131","year":"2021","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.diabet.2015.02.005","article-title":"Evaluation of the relationship between cardiovascular risk factors and periaortic fat thickness in children with type 1 diabetes mellitus","volume":"41","author":"Aky\u00fcrek","year":"2015","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association (APA)","year":"2013"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111954_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144372","article-title":"A novel anti-inflammatory effect for high density lipoprotein","volume":"10","author":"Cameron","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/0091270009336736","article-title":"Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data","volume":"49","author":"Charach","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111954_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.20","article-title":"Attention-deficit\/hyperactivity disorder","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0040","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2011.1830","article-title":"ADHD medications and risk of serious cardiovascular events in young and middle-aged adults","volume":"306","author":"Habel","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0045","first-page":"2331","article-title":"Long-term ADHD medications and cardiovascular disease risk","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1383032","article-title":"Seven psychiatric traits and the risk of increased carotid intima-media thickness: a Mendelian randomization study","volume":"11","author":"He","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","article-title":"Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features","volume":"22","author":"Iacobellis","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111954_bb0060","article-title":"A cross-cohort study examining the associations of metabolomic profile and subclinical atherosclerosis in children and their parents: the child health CheckPoint study and Avon longitudinal study of parents and children","volume":"8","author":"Juonala","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4274\/npa.y6219","article-title":"Conners parent rating scale-revised short: Turkish standardization study\/Conners anababa dereceleme olcegi-yenilenmis kisa: Turkiye stardardizasyon calismasi","volume":"50","author":"Kaner","year":"2013","journal-title":"Arch. Neuropsychiatr."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0070","article-title":"Novel hematologic ratios and systemic inflammation index in ADHD: effects of methylphenidate treatment","volume":"16","author":"Ka\u015fak","year":"2025","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0075","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1022602400621","article-title":"The revised Conners' parent rating scale (CPRS-R): factor structure, reliability, and criterion validity","volume":"26","author":"Keith Conners","year":"1998","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0085","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000489635","article-title":"A review on the role of inflammation in attention-deficit\/hyperactivity disorder","volume":"25","author":"Leffa","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2215-0366(23)00042-1","article-title":"Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the attention deficit hyperactivity disorder drugs use chronic effects (ADDUCE) study","volume":"10","author":"Man","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","article-title":"Interaction between high-density lipoproteins and inflammation: function matters more than concentration!","volume":"159","author":"Nazir","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4274\/jcrpe.2183","article-title":"Reference values for weight, height, head circumference, and body mass index in Turkish children","volume":"7","author":"Neyzi","year":"2015","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-021-00647-9","article-title":"Prevention of atherosclerosis from childhood","volume":"19","author":"Raitakari","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1060028013510699","article-title":"A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)","volume":"48","author":"Sharma","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0125","article-title":"Cardiovascular safety of methylphenidate among children and young people with attention-deficit\/hyperactivity disorder (ADHD): nationwide self controlled case series study","volume":"353","author":"Shin","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111954_bb0135","first-page":"33","article-title":"Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T)","volume":"30","author":"\u00dcnal","year":"2019","journal-title":"Turk. Psikiyatri Derg."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0140","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.109.192639","article-title":"Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association","volume":"54","author":"Urbina","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.9758\/cpn.2023.21.1.77","article-title":"Cardiovascular disease risk in children and adolescents with attention deficit\/hyperactivity disorder","volume":"21","author":"Uzun","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111954_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.43597","article-title":"Risk of cardiovascular diseases associated with medications used in attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"5","author":"Zhang","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pnpbp.2026.111954_bb0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamapsychiatry.2023.4294","article-title":"Attention-deficit\/hyperactivity disorder medications and long-term risk of cardiovascular diseases","volume":"81","author":"Zhang","year":"2024","journal-title":"JAMA Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626003520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626003520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:49:07Z","timestamp":1793476147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626003520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S0278584626003520"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111954","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylphenidate treatment status and subclinical atherosclerosis in children and adolescents with ADHD: a cross-sectional comparative study","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111954"}}